Register entry

Cayman Pharma s.r.o.

Data as of · How to read this entry

Registered sites
1
Active NDC listings
7
Labeller names
2
Live patents
0
Countries
1
Base
Czechia
Sites

Registered establishments

1
EstablishmentAddressRegistered forFEI / DUNS
Cayman Pharma s.r.o.Prace 657, Neratovice, 27711, Czech Republic (CZE)Active ingredient (API) manufacture3003625059495076551
Catalogue

Drug listings by form and route

7

7 active NDC listings: 7 bulk ingredient. By marketing category: BULK INGREDIENT 7.

Dosage formNDCs
oil3
powder3
liquid1
RouteNDCs
Labeller name on the listingNDCs
cayman pharma s.r.o.5
cayman pharma s r.o.2
Catalogue

Marketed products

7
BrandGeneric nameForm / routeNDC
-Bimatoprostpowder61556-070BULK INGREDIENT
-Cloprostenol sodiumpowder61556-001BULK INGREDIENT
-Epoprostenol sodiumpowder61556-030BULK INGREDIENT
-Latanoprostoil61556-050BULK INGREDIENT
-Latanoprostene Bunodliquid61556-090BULK INGREDIENT
-Tafluprostoil61556-080BULK INGREDIENT
-Travoprostoil61556-040BULK INGREDIENT
Compare

Comparable companies in Czechia

Enquiry

Common questions

Is Cayman Pharma s.r.o. FDA approved?
Cayman Pharma s.r.o. holds 1 FDA-registered establishment in Czechia. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
Where are Cayman Pharma s.r.o.'s drugs manufactured?
The FDA register lists Neratovice. Registered operations: active ingredient (API) manufacture.
What drugs does Cayman Pharma s.r.o. make?
7 products are listed under Cayman Pharma s.r.o. in the openFDA NDC Directory, most often as oil; powder; liquid. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.